Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.10
-0.1700-1.39%
Volume:447.19K
Turnover:5.45M
Market Cap:1.96B
PE:549.05
High:12.43
Open:12.30
Low:12.05
Close:12.27
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.45
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.13
PE(LYR):272.55

Loading ...

Vertex Pharmaceuticals Price Target Raised to $560.00/Share from $515.00 by JP Morgan

Dow Jones
·
Yesterday

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Yesterday

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Vertex CEO, CFO to Speak at Goldman Sachs Communacopia + Technology Conference

Reuters
·
Sep 03

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating

MT Newswires Live
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02

Vertex Pharmaceuticals Price Target Announced at $665.00/Share by Morgan Stanley

Dow Jones
·
Sep 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 02

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley

TIPRANKS
·
Sep 02

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Sep 01

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Sep 01

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Sep 01